ORCHPHARMA.NSORCHPHARMA.NSNSE
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank29
3Y CAGR+69.9%
5Y CAGR-25.2%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+69.9%/yr
vs -40.8%/yr prior
5Y CAGR
-25.2%/yr
Recent acceleration
Acceleration
+110.7pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $211.07M | +486.2% |
| 2024 | $36.01M | -84.1% |
| 2023 | $225.97M | +424.7% |
| 2022 | $43.07M | -72.6% |
| 2021 | $156.94M | -82.5% |
| 2020 | $898.91M | -2.6% |
| 2019 | $923.11M | +162.9% |
| 2018 | $351.13M | +70.5% |
| 2017 | $205.98M | -93.5% |
| 2016 | $3.15B | - |